Conference Coverage: ESMO 2023 – Focus on Genitourinary (GU) Malignancies
Impact of recent ESMO data on clinical practice and therapy guidance in GU cancers
November 1, 2023
FACULTY CHAIR
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Faculty Members
Scott Tagawa, MD, FACP, FASCO
Weill Cornell Medicine, New York, NY, USA
Leonard G. Gomella, MD, FACS
Thomas Jefferson University, Philadelphia, PA, USA
Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA
Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Karim Fizazi, MD, PhD
Gustave Roussy Institute, Villejuif, France
Manuela Schmidinger, MD
Medical University of Vienna, Austria
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Metastatic Castration-Resistant Prostate Cancer
- Hormone-Sensitive Prostate Cancer
- Bladder Cancer Part 1 – NMIBC and MIBC
- Bladder Cancer Part 2 – Therapies for Metastatic Disease
- Clear Cell Renal Cell Carcinoma
